Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Before taking Paxlovid, consider these drug interactions

Param Patel, PharmD
Meds
April 7, 2022
Share
Tweet
Share

FDA and Health Canada recently approved Paxlovid as an oral treatment option for mild-to-moderate COVID-19 who are at high risk of progression to severe COVID-19. It is a combination drug containing nirmatrelvir/ritonavir. Nirmatrelvir works by binding to SARS-CoV-2 3CL protease to ultimately stop viral replication. Ritonavir does not have any antiviral activity against COVID-19 but increases concentrations of nirmatrelvir by decreasing its metabolism by CYP3A4 enzyme. Ritonavir is a potent inhibitor of CYP3A4 and various drug transporters such as P-glycoprotein. CYP3A4 and P-glycoprotein are involved in the metabolism and elimination of many commonly prescribed drugs. Thus it is very important to review a patient’s current medication regimen to check for clinically significant interactions.

Potential medication interaction management options may include depending on the medication:

  • Holding the interacting medication and resuming two days after completing the Paxlovid course
  • Using an alternative medication that does not interact or adjusting the dose of the interacting medication while on Paxlovid
  • Use an alternative COVID-19 agent.

I will discuss Paxlovid interactions with some commonly prescribed medications and potential management options. It is not an exhaustive list, and a pharmacist consultation with the patient may be helpful before prescribing Paxlovid for a comprehensive review of interactions.

CYP3A-4 inducing medications 

Paxlovid is contraindicated in patients taking any CYP3A4 inducing agent as these medications significantly decrease the concentration of Paxlovid and thus decrease its effectiveness. Holding the interacting medicines is not an option as the enzyme induction effect does not immediately dissipate when a medication is stopped. Alternative COVID treatment should be considered in patients that have taken an enzyme inducer within the past 14 days. Common drugs include anticonvulsants (carbamazepine, eslicarbazepine, oxcarbazepine, phenobarbital, phenytoin, primidone), antimycobacterials (rifampin), and St. John’s Wort.

Medications dependent on CYP3A4 metabolism 

The onset of CYP3A4 inhibition by ritonavir is rapid and significant. It can lead to high serum concentrations of some medications which can lead to serious adverse events. For drugs with a prolonged half-life, stopping the medication will not help reduce the interaction risk as the medication is slowly eliminated from the body, and an alternative COVID-19 treatment should be used. Common drugs include antiarrhythmics (amiodarone, dronedarone, flecainide, propafenone, quinidine), antipsychotics (lurasidone, clozapine), and fentanyl.

Some medications may either be held, dose-adjusted, or changed to alternative therapy temporarily while on Paxlovid.

Anticoagulants (apixaban, edoxaban, rivaroxaban): Use alternative COVID-19 agent if possible. Otherwise, if used for venous thromboembolism; the anticoagulant should be held and restarted two days after completing the Paxlovid course and the patient should be bridged with a low molecular weight heparin. For atrial fibrillation, apixaban and edoxaban may be dose adjusted or an alternative COVID-19 treatment should be considered. There is no dose adjustment recommended for rivaroxaban; an alternative should be considered. If clinically appropriate, patients on warfarin should be monitored for signs of increased bleeding/bruising and INR.

Alfuzosin: Alfuzosin levels may be increased significantly; hold and restart two days after Paxlovid is completed.

Opioids (hydrocodone, oxycodone, tramadol): Opioid dose should be reduced temporarily and resume the usual dose two days after Paxlovid is completed.

Calcium channel blockers (amlodipine, diltiazem, felodipine, nifedipine, verapamil): Consider reducing the dose temporarily and resume the usual dose two days after Paxlovid is completed.

Atorvastatin/rosuvastatin: Hold and restart the usual dose two days after Paxlovid is completed. Dose reduction may be considered.

ADVERTISEMENT

The list of interactions with Paxlovid is long. These are some of the commonly used medications that interact with Paxlovid and management strategies. Pharmacists can be a valuable resource for assessing and helping manage these interactions.

Param Patel is a pharmacist.

Image credit: Shutterstock.com

Prev

Will Biden's State of the Union remarks revive prescription drug reform?

April 7, 2022 Kevin 0
…
Next

Primary care should be the center of gravity in health care [PODCAST]

April 7, 2022 Kevin 0
…

Tagged as: COVID, Infectious Disease, Medications

Post navigation

< Previous Post
Will Biden's State of the Union remarks revive prescription drug reform?
Next Post >
Primary care should be the center of gravity in health care [PODCAST]

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Related Posts

  • A drug problem in rural Georgia

    Ashish Advani, PharmD
  • How hospitals can impact generic drug companies

    Mark Kelley, MD
  • Drug ads are a campaign against physician trust

    Judy Salz, MD
  • Crippling drug costs: the role of insurers

    Janice Boughton, MD
  • The complications of drug regulation

    Julie Craig, MD
  • A missed opportunity to fix drug pricing

    Brian C. Joondeph, MD

More in Meds

  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • The anesthesia spectrum: Guiding patients through comfort options in oral surgery

    Dexter Mattox, MD, DMD
  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why recovery after illness demands dignity, not suspicion

      Trisza Leann Ray, DO | Physician
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • Bureaucracy over care: How the U.S. health care system lost its way

      Kayvan Haddadan, MD | Physician
    • Reclaiming trust in online health advice [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • Reclaiming trust in online health advice [PODCAST]

      The Podcast by KevinMD | Podcast
    • The business lesson new doctors must unlearn

      Stanley Liu, MD | Finance
    • 9 proven ways to gain cooperation in health care without commanding

      Patrick Hudson, MD | Physician
    • Closing the gap in respiratory care: How robotics can expand access in underserved communities

      Evgeny Ignatov, MD, RRT | Tech
    • Model context protocol: the standard that brings AI into clinical workflow

      Harvey Castro, MD, MBA | Tech
    • Bird flu’s deadly return: Are we flying blind into the next pandemic?

      Tista S. Ghosh, MD, MPH | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why recovery after illness demands dignity, not suspicion

      Trisza Leann Ray, DO | Physician
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • Bureaucracy over care: How the U.S. health care system lost its way

      Kayvan Haddadan, MD | Physician
    • Reclaiming trust in online health advice [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • Reclaiming trust in online health advice [PODCAST]

      The Podcast by KevinMD | Podcast
    • The business lesson new doctors must unlearn

      Stanley Liu, MD | Finance
    • 9 proven ways to gain cooperation in health care without commanding

      Patrick Hudson, MD | Physician
    • Closing the gap in respiratory care: How robotics can expand access in underserved communities

      Evgeny Ignatov, MD, RRT | Tech
    • Model context protocol: the standard that brings AI into clinical workflow

      Harvey Castro, MD, MBA | Tech
    • Bird flu’s deadly return: Are we flying blind into the next pandemic?

      Tista S. Ghosh, MD, MPH | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...